Epidemiology of neural tube defect subtypes in Tunisia, 1991-2011

Pathology Research and Practice

Volumn 210, Issue 12, 2014, Pages 944-952

  Nasri, Kaouther ^a   Ben Fradj, Mohamed Kacem ^b   Hamdi, Thouraya ^c   Aloui, Mariem ^a   Ben Jemaa, Nadia ^a   Nahdi, Saber ^a   Guesmi, Refka ^a   Masmoudi, Aida ^a   Elmay, Michèle Véronique ^b   Marrakchi, Raja ^d   Siala Gaigi, Soumeya ^a  

^a Centre de Maternite et de Neonatologie Tunis   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

^d FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

Author keywords

Anencephaly; Encephalocele; Epidemiology; Neural tube defects; Spina bifida

Indexed keywords

ADULT; ANENCEPHALUS; ARTICLE; BLOOD GROUP O; BRAIN DEVELOPMENT; CHILD; CONSANGUINITY; CONTROLLED STUDY; ENCEPHALOCELE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; MOTHER FETUS RELATIONSHIP; NEURAL TUBE DEFECT; NEURULATION; PREGNANCY; PREVALENCE; PROBABILITY; RISK FACTOR; SPINAL CORD; STILLBIRTH; TUNISIA; ANENCEPHALY; NEWBORN; SEX DIFFERENCE; SPINAL DYSRAPHISM;

ADULT; ANENCEPHALY; ENCEPHALOCELE; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREVALENCE; RISK FACTORS; SEX FACTORS; SPINAL DYSRAPHISM; TUNISIA;

EID: 84949114266     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.06.027     Document Type: Article

References (19)

1. Rampersaud E., Bassuk A.G., Enterline D.S., George T.M., Siegel D.G., Melvin E.C., et al. Whole genome wide linkage screen for neural tube defects reveals regions of interest on chromosomes 7 and 10. J. Med. Genet. 2005, 42:940-946.
2. Copp A.J., Brook F.A., Estibeiro J.P., Shum A.S., Cockroft D.L. The embryonic development of mammalian neural tube defects. Prog. Neurobiol. 1990, 35:363-403.
3. Agha M.M., Glazier R.H., Moineddin R., Moore A.M., Guttmann A. Food fortification and decline in the prevalence of neural tube defects: does public intervention reduce the socioeconomic gap in prevalence?. Int. J. Environ. Res. Public Health. 2013, 10:1312-1323.
4. De Wals P., Tairou F., van Allen M.I., Uh S., Lowry R.B., Sibbald B., Evans J.A., Van Den Hof M.C., Zimmer P., Crowley M., et al. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 2007, 357:135-142.
5. Williams L.J., Rasmussen S.A., Flores A., Kirby R.S., Edmonds L.D. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005, 116:580-586.
6. Canfield M.A., Collins J.S., Botto L.D., Williams L.J., Mai C.T., Kirby R.S., Pearson K., Devine O., Mulinare J. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res. A Clin. Mol. Teratol. 2005, 73:679-689.
7. Poloce F., et Boisson-Gaudin C. Marqueurs sériques maternels d'anomalies fœtales (trisomie 21, anomalies chromosomiques, spina bifida,...). Revue Francophone Des Laboratoires 2010, 421:59-68.
8. Zlotogora J. Hereditary disorders among Iranian Jews. Am. J. Med. Genet. 1995, 58:32-37.
9. Obeidat A.Z., Amarin Z. Neural tube defects in the north of Jordan: is there a seasonal variation?. J. Child Neurol. 2010, 25:864-866.
10. Bound J.P., Harvey P.W., Francis B.J. Seasonal prevalence of major congenital malformations in the Fylde of Lancashire 1957-1981. J. Epidemiol. Community Health 1989, 43:330-342.
11. Fornoff J.E., Egler T., Shen T. Prevalence of Neural Tube Defects in Illinois 1989-2002. Epidemiological Report Series 04:02 2004, Illinois Department of Public Health, Springfield.
12. Whiteman D., Murphy M., Hey K., O'Donnell M., Goldacre M. Reproductive factors, subfertility and risk of neural tube defects: a case-control study based on the Oxford Record Linkage Study Register. Am. J. Epidemiol. 2000, 152:823-828.
13. Hendricks K.A., Simpson J.S., Larsen R.D. Neural tube defects along the Texas-Mexico border, 1993-1995. Am. J. Epidemiol. 1999, 149:1119-1127.
14. Owen T.J., Halliday J.L., Stone C.A. Neural tube defects in Victoria, Australia: potential contributing factors and public health implications. Aust. N. Z. J. Public Health 2001, 24:584-589.
15. Vieira A.R. Birth order and neural tube defects: a reappraisal. J. Neurol. Sci. 2004, 217:65-72.
16. Farley T. Epidemiologic evidence linking ABO and Rh blood groups in the mother with neural tube defect lesion level in the child. Cerebrospinal Fluid Research. Poster from 50th Annual Meeting of the Society for Research into Hydrocephalus and Spina Bifida Cambridge, UK. 30 August-2 September 2006 2006.
17. Aubdool B.R. Apport de l'examen foetopathologique dans l'identification des malformations neurologiques et leurs preventions. Experience du centre de maternité de Tunis 1995, (Thèse de doctorat en médecine Tunis), 100 pages.
18. Wu O., Bayoumi N., Vickers M.A., Clark P. ABO (H) blood groups and vascular disease. J. Thromb. Haemost. 2008, 6:62-69.
19. Clark P., Wu O. ABO (H) blood groups and pre-eclampsia. Thromb. Haemost. 2008, 100:469-474.